ANZUPGO FDA approval date

The FDA approved ANZUPGO on 23 Jul 2025.

FDA approval date
23 Jul 2025

Drug identity has not yet been verified against registry records

Also recorded as DELGOCITINIB

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2025-07-23DayANZUPGOFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA219155", "applicant_as_listed_by_fda": "LEO PHARMA AS", "brand_names": ["ANZUPGO"], "active_ingredients": ["DELGOCITINIB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20250723", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026